Publication

A Randomized Phase II Study of Nivolumab Plus Ipilimumab Versus Standard of Care in Previously Untreated and Advanced Non-Clear Cell Renal Cell Carcinoma (Suniforecast)

Ahrens, M., Escudier, B., Boleti, E., Grimm, M-O., Goupir, M. G., Barthelemy, P., Gravis, G., Bedekes, J., Ivanyi, P., Panic, A., Zschaebitz, S., Neyrieru, S., Mellado, B., Biel, A., Wadell, T., Pablo Maroto, J., Retz, M., Boegemann, M., Rottey, S., Haanen, J., Oosting, S., Castellano, D., Hartmann, A. & Bergmann, L., Feb-2020, In : Oncology Research and Treatment. 43, p. 226-226 1 p.

Research output: Contribution to journalMeeting AbstractAcademic

  • Marit Ahrens
  • Bernard Escudier
  • Ekaterini Boleti
  • Marc-Oliver Grimm
  • Marine Gross Goupir
  • Pilippe Barthelemy
  • Gwenaelle Gravis
  • Jens Bedekes
  • Philipp Ivanyi
  • Andrej Panic
  • Stefanie Zschaebitz
  • Sylvie Neyrieru
  • Begona Mellado
  • Anika Biel
  • Tom Wadell
  • Jose Pablo Maroto
  • Margitta Retz
  • Martin Boegemann
  • Sylvie Rottey
  • John Haanen
  • Sjoukje Oosting
  • Daniel Castellano
  • Arndt Hartmann
  • Lothar Bergmann
Original languageEnglish
Pages (from-to)226-226
Number of pages1
JournalOncology Research and Treatment
Volume43
Publication statusPublished - Feb-2020

ID: 120716205